A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study for the Pain of Diabetic Peripheral Neuropathy

NCT01521598 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

128

Enrollment

INDUSTRY

Sponsor class

Conditions

Painful Diabetic Neuropathy

Interventions

DRUG: SKL11197
DRUG: Placebo

Sponsor

SK Life Science, Inc.